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G Protein-coupled Receptors*□S
Pascal Maurice‡§, Avais M. Daulat‡§¶, Ce´dric Broussard§, Julien Mozo**,
Guilhem Clary§, Franc¸oise Hotellier§, Philippe Chafey§, Jean-Luc Guillaume‡§,
Gilles Ferry**, Jean A. Boutin**, Philippe Delagrange**, Luc Camoin§,
and Ralf Jockers‡§‡‡
G protein-coupled receptors (GPCRs) constitute the larg-
est family of membrane receptors and are major drug
targets. Recent progress has shown that GPCRs are part
of large protein complexes that regulate their activity. We
present here a generic approach for identification of these
complexes that is based on the use of receptor subdo-
mains and that overcomes the limitations of currently
used genetics and proteomics approaches. Our approach
consists of a carefully balanced combination of chemi-
cally synthesized His6-tagged baits, immobilized metal
affinity chromatography, one- and two-dimensional gel
electrophoresis separation and mass spectrometric iden-
tification. The carboxyl-terminal tails (C-tails) of the hu-
man MT1 and MT2 melatonin receptors, two class A
GPCRs, were used as models to purify protein complexes
from mouse brain lysates. We identified 32 proteins that
interacted with the C-tail of MT1, 14 proteins that inter-
acted with the C-tail of MT2, and eight proteins that
interacted with both C-tails. Several randomly selected
proteins were validated by Western blotting, and the
functional relevance of our data was further confirmed
by showing the interaction between the full-length MT1
and the regulator of G protein signaling Z1 in trans-
fected HEK 293 cells and native tissue. Taken together,
we have established an integrated and generic purifica-
tion strategy for the identification of high quality and
functionally relevant GPCR-associated protein com-
plexes that significantly widens the repertoire of avail-
able techniques. Molecular & Cellular Proteomics 7:
1556–1569, 2008.
G protein-coupled receptors (GPCRs)1 constitute the larg-
est family of membrane receptors with more than 800 mem-
bers (1, 2). By binding to a great variety of ligands (photons,
odorants, amino acids, nucleotides, peptides, proteins, and
lipids), GPCRs are key receptors of numerous physiological
processes such as neurotransmission, cell metabolism, se-
cretion, cell differentiation, and growth and are targeted by
about half of the drugs prescribed for human diseases (3). It is
now well established that GPCRs do not only couple to het-
erotrimeric G proteins but can also physically associate with
other less well known intracellular proteins regulating receptor
trafficking, subcellular localization, signaling, and desensitiza-
tion (4, 5). Intracellular proteins can interact directly or
indirectly, via adaptor proteins, with intracellular receptor do-
mains. Among these domains, the carboxyl-terminal tail (C-
tail) is considered a key domain able to recruit intracellular
proteins in large submembrane signaling networks (6, 7).
Several approaches have been described in the literature to
identify proteins that interact with GPCRs. The yeast two-
hybrid assay has been used to screen for proteins that bind to
cytosolic domains of GPCRs (8–10). However, this system,
which is very sensitive for the detection of in vivo protein-
protein interactions, has shown several limitations including
the generation of many false positives and negatives, the
detection of only binary interactions, and the non-physiolog-
ical relevance of the identified interactions (e.g. occurring in
the yeast nucleus). Moreover this approach is not designed to
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identify protein complexes. To overcome these limitations,
proteomics approaches were developed based on peptide
affinity chromatography coupled to protein identification by
mass spectrometry. The first generation used the entire re-
ceptor C-tail expressed as a GST fusion protein in Escherichia
coli to purify the interactome of the C-tail from brain lysates
(11). Although some interacting proteins have been identified
for the 5-HT2C receptor, several limitations prevented a more
general application of this approach. Indeed the amount of
nonspecifically retained proteins is high because of the pres-
ence of contaminating bacterial proteins, full-length and trun-
cated GST fusion proteins, and proteins that nonspecifically
bind to the GST carrier. In addition, the complex sample has
to be separated by two-dimensional (2D) electrophoresis be-
fore mass spectrometry analysis of the recruited proteins,
thus minimizing the number of potential candidates because
of the limitations inherent to 2D electrophoresis for hydropho-
bic, basic, and large proteins. The second generation of pep-
tide affinity chromatography is based on the use of short
synthetic peptides encompassing a specific interaction motif
that recruit only the proteins that interact with this specific
motif. The amount of nonspecific proteins is indeed largely
reduced in this approach, and the pattern of specific interac-
tion partners is much less complex. Consequently this ap-
proach has been successfully used for several GPCRs and is
expected to be applied to multiple GPCR interaction motifs
(12, 13). However, this evolution of peptide affinity chroma-
tography does not respond to the initial task, the identification
of the interactome of the entire C-tail, without prior knowledge
of specific interaction motifs.
In the present study, we present an improved peptide af-
finity chromatography that has the potential to become the
first generic approach for the purification of GPCR C-tail-
associated protein complexes. We combined the use of
chemically synthesized His6-tagged peptides encompassing
the entire receptor C-tail combined with metal affinity immo-
bilization on a Ni-NTA matrix to recover protein complexes
from mouse brain lysates. The C-tails of the MT1 and MT2
melatonin receptors, typical class A GPCRs, were used as
model receptors. Major features of this approach are the low
nonspecific binding, the high integrity of recovered com-
plexes, and the compatibility with 1D and 2D electrophoresis.
We report the identification of 40 and 22 proteins that specif-
ically associate with the C-tails of MT1 and MT2, respectively.
To demonstrate the functional relevance of the identified pro-
tein complexes, we selected the interaction between MT1 and
the regulator of G protein signaling Z1 (RGSZ1) for further
characterization in transfected HEK 293 cells and native
tissue.
EXPERIMENTAL PROCEDURES
Peptide Affinity Chromatography—Peptides encompassing the C-
tails of the MT1 and MT2 receptors were chemically synthesized by
NeoMPS (Strasbourg, France) with a His6 tag at the amino terminus.
The synthetic peptides (MT1, last 61 amino acids, 7.16 kDa, 88.5%
purity; MT2, last 58 amino acids, 6.80 kDa, 90% purity) were coupled
via the His6 tag to Ni-NTA-agarose beads (Qiagen).
Brains of C57/Bl6 mice were crushed in 20 ml of buffer containing
20 mM NaH2PO4, 2 mM Na3VO4, 10 mM NaF, protease inhibitor
mixture EDTA-free (Roche Applied Science), pH 8.0, using an Ultra-
Turrax T25 (Janke-Kunkel). CHAPS (10 mM final concentration) and
NaCl (150 mM final concentration) were added, and the homogenates
were incubated for 3 h at 4 °C under gentle end-over-end mixing.
After centrifugation (10,000 g for 1 h at 4 °C), the supernatants were
collected, and the protein concentration was determined by BCA
assay (Pierce).
Supernatants (10 mg of solubilized brain proteins) were incubated
overnight at 4 °C with 20 l of Ni-NTA-agarose beads (300–350 g of
immobilized peptide) in the presence of 20 mM imidazole to reduce
nonspecific binding. The beads were washed five times in washing
buffer (20 mM NaH2PO4, 2 mM Na3VO4, 10 mM NaF, protease inhibitor
mixture EDTA-free, 10 mM CHAPS, 150 mM NaCl, 20 mM imidazole,
pH 8), and proteins retained by affinity were eluted with either 50 l of
2% SDS in PBS (95 °C for 10 min) for BCA measurements, 1D
electrophoresis, and immunoblotting or 200 l of rehydration buffer (8
M urea, 2 M thiourea, 4% CHAPS) for 45 min at room temperature for
2D electrophoresis.
1D and 2D Electrophoresis—For 1D electrophoresis, eluted pro-
teins with 2% SDS in PBS were denatured in SDS-PAGE loading
buffer (62.5 mM Tris/HCl, pH 6.8, 2% SDS, 10% glycerol, 0.5%
bromphenol blue) for 5 min at 95 °C. Samples were subjected to
SDS-PAGE on a 10 or 5–9% gradient polyacrylamide gel, and pro-
teins were silver-stained according to Rabilloud and Charmont (14).
For 2D electrophoresis, eluted proteins in rehydration buffer were
first separated according to their isoelectric point along a nonlinear
IPG strip (pH 3–11 nonlinear, 11 cm long) using the IPGphor appara-
tus (GE Healthcare). DeStreack Reagent (15 mg/ml of rehydration
solution; GE Healthcare) and ampholytes (1% IPG buffer; GE Health-
care) were added to the sample, and then sample loading for the first
dimension was performed by passive in-gel rehydration. Focalization
was stopped when 27,000 V-h were reached. After the first dimen-
sion, the IPG strips were equilibrated for 15 min in buffer A (6 M urea,
2% SDS, 30% glycerol, 50 mM Tris/HCl, pH 8.6) containing 1% DTT
and then for 15 min in buffer A containing 4.7% iodoacetamide. For
the second dimension, the strips were loaded on 8–18% SDS-poly-
acrylamide gels. The gels were then silver-stained according to Ra-
billoud and Charmont (14).
In-gel Trypsin Digestion—Spots of interest were excised from the
gel, washed with 200 mM ammonium bicarbonate (ABC) and imme-
diately destained according to Gharahdaghi et al. (15). In-gel trypsin
digestion was carried out as described in a protocol based on the
ZipTip Plate (Millipore) with minor modifications. After destaining,
spots were rinsed three times with water and shrunk with 50 mM ABC,
50% ACN for 20 min at room temperature. Gel pieces were dried
using 100% ACN for 15 min and then incubated in 50 mM ABC
containing 10 mM DTT for 1 h at 56 °C. The solution was then
replaced by 55 mM iodoacetamide in 50 mM ABC for 30 min in the
dark at room temperature. The gel pieces were washed twice with 50
mM ABC, finally shrunk with 25 mM ABC, 50% ACN for 30 min, and
dried using 100% ACN for 10 min. Gel pieces were rehydrated in 20
l of 40 mM ABC, 10% ACN, pH 8.0, containing 12.5 g/ml sequenc-
ing grade modified trypsin (Promega). Proteins were digested over-
night at 37 °C. After digestion, the gel pieces were shrunk with 100%
ACN, and peptides were extracted with 0.2% TFA. Peptides were
then desalted using C18 phase on a ZipPlate. Two elutions were
performed successively to recover products from the C18 phase, first
with 50% ACN, 0.1% TFA and then using 90% ACN, 0.1% TFA.
Pooled elutions were concentrated using a vacuum centrifuge (Ep-
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pendorf), and generated peptides were redissolved in 3 l of 1%
formic acid before mass spectrometry analysis.
Protein Identification by MALDI-TOF Mass Spectrometry—Di-
gested samples were spotted directly onto a 96  2 MALDI plate
(Applied Biosystems) using the dried droplet method (0.5 l of the
sample mixed on the plate with 0.5 l of -cyano-4-hydroxycinnamic
acid matrix in ACN/water/TFA (50:50:0.1%). Droplets were allowed to
dry at room temperature. Mass spectrometry analysis were per-
formed on a MALDI-TOF Voyager DE-PRO mass spectrometer
(Applied Biosystems) and acquired in positive ion reflector mode.
Spectra were obtained in a reflectron-delayed extraction in source
over a mass range of 500–3500 daltons. Raw spectra were treated
automatically according to the Mascot wizard algorithm (version
1.1.2.0, Matrix Science) using the default parameters with the ex-
ception of the maximum peak count reduced to a value correspond-
ing to the expected number of tryptic peptides according to the
experimental molecular weight of the protein. The protein database
was restricted to the rodent entries of the comprehensive nonredun-
dant protein sequence database (NCBInr database; National Center
for Biotechnology Information) (from version October 2005, 118,719
entries to version October 2007, 217,820 entries). When non-signifi-
cant scoring was obtained, a manual treatment was performed ac-
cording to the following explanations. First raw spectra were treated
using a noise filter algorithm (correlation factor, 0.7) and the default
advanced base-line correction. Then monoisotopic masses were
generated on a fully detected spectrum after internal calibration using
autodigestion tryptic peptides or external calibration using a mixture
of five external standards (PepMix 1, LaserBio Labs, Sophia Antipolis,
France). Mains peaks were selected according to local background,
molecular weight of the protein, and known peak contamination from
trypsin and keratin using PeakErazor software (version 1.49, Light-
house Data, Odense, Denmark). Searches were carried out using four
different algorithms for protein identification: Mascot (version 2.1,
Matrix Science), ProFound (version 2005.02.14, Proteometrics), MS-
Fit (version 3.2.1, ProteinProspector), and Aldente (version
2006.09.11, ExPASy) softwares on the rodent entries of the NCBInr
database. A combination of results from different algorithms offers
the option to cross-validate and consolidate the identification through
the complementary use of several packages. Allowed variable mod-
ifications were oxidation of methionine, acrylamide-modified cys-
teine, and carbamidomethylation of cysteine. Up to one missed tryp-
tic cleavage was considered, and a mass accuracy in the range of
25–50 ppm was used for all tryptic mass searches. Identification was
considered positive if the protein was identified with the most ele-
vated score using at least two algorithms. For a protein with a score
close to the threshold value, the identification was rejected. Identified
proteins are listed in Tables I and II. If peptides matched to multiple
members of a protein family, the protein with the highest number of
matched peptides and experimental molecular weight and isoelectric
point close to theoretical parameters was indicated in the table, and
NCBI accession numbers of the other isoforms are mentioned at the
bottom of the table.
Antibodies—Monoclonal anti-14-3-3  and anti-PP2A (catalytic
subunit, clone 1D6) and polyclonal anti-Gi3, anti-neuronal NO syn-
thase (nNOS), anti-panPKCs, anti-PKC , anti-14-3-3 , anti-PP2A-A
/ (regulatory subunit), and anti-c-Myc antibodies were purchased
from Santa Cruz Biotechnology. Monoclonal anti-postsynaptic den-
sity (PSD)-95 antibodies (clone K28/86.2) were from Upstate Biotech-
nology. Polyclonal anti-FLAG and monoclonal anti-tubulin  (clone
DM 1A), anti-tubulin  (clone TUB 2.1), anti-tubulin  (clone GTU-88),
and anti-FLAG M2 antibodies were from Sigma. Monoclonal anti-HA
(clone 12CA5) and anti-G protein-coupled receptor kinase (GRK) 2/3
(clone C5/1.1) antibodies were purchased from Roche Diagnostics
and Millipore, respectively. CyTM3-conjugated goat anti-mouse anti-
bodies were from Jackson ImmunoResearch Laboratories, and
horseradish peroxidase-conjugated secondary antibody was from
Pierce. Polyclonal anti-otubain 1 and anti-MUPP1 antibodies were a
kind gift from Dr. M. Y. Balakirev (Grenoble, France) and Dr. R. T.
Javier (Houston, TX), respectively. Polyclonal anti-RGSZ1 antibodies
were kindly provided by Dr. J. Garzon (Madrid, Spain).
Plasmids—The cDNA encoding HA-RGSZ1 was purchased from
the University of Missouri Rolla cDNA Resource Center (Rolla, MO),
and pGEX-4T-1 vector was from Amersham Biosciences. The cDNA
encoding Myc-RGS10 was a kind gift from Dr. P. J. Casey (Durham,
NC). The FLAG-MT1 protein construct has been described elsewhere
(16). The FLAG-MT2 construct was obtained by a PCR-based ap-
proach using a Myc-MT2 cDNA (16) and the Phusion High-Fidelity
DNA Polymerase (Finnzymes). Restriction sites for EcoRI and XbaI
were introduced immediately adjacent to the initiation and termination
codons of MT2 by PCR. After digestion by the respective restriction
enzymes, the resulting insert was ligated into a pcDNA3.1 vector
encoding FLAG. All constructs were confirmed by sequencing.
Cell Culture and Transfection—HEK 293 cells were grown in Dul-
becco’s modified Eagle’s medium supplemented with 10% fetal calf
serum, 100 units/ml penicillin, 0.1 mg/ml streptomycin, 0.02 M HEPES
and transfected at 40–50% confluence using FuGENE 6 (Roche
Applied Science).
Immunoprecipitation—HEK 293 cells grown in 100-mm culture
dishes were transiently transfected by 4 g of either FLAG-MT1 or
FLAG-MT2 cDNAs together with 4 g of HA-RGSZ1 or Myc-RGS10
cDNAs. 48 post-transfection, cells were stimulated, or not, by 107 M
melatonin for 15 min at 37 °C, washed three times in PBS, and lysed
in 1.5 ml of cold lysis buffer (75 mM Tris, 2 mM EDTA, 12 mM MgCl2,
10 mM CHAPS, pH 7.4). After sonication, receptors were solubilized
for 3 h at 4 °C under gentle end-over-end mixing, and lysates were
centrifuged at 12,000  g for 1 h at 4 °C. Receptor immunoprecipi-
tation was performed on 1 ml of supernatant using 4 g of polyclonal
anti-FLAG antibodies preadsorbed on protein G-Sepharose beads
(Sigma). Immunoprecipitated proteins were eluted with 50 l of SDS-
PAGE sample buffer (62.5 mM Tris/HCl, pH 6.8, 2% SDS, 10% glyc-
erol, 100 mM DTT, 0.5% bromphenol blue) for 10 min at 95 °C and
subjected to SDS-PAGE and immunoblotting.
Immunoblotting—Proteins resolved by 1D electrophoresis were
transferred onto nitrocellulose membrane (Whatman GmbH). After
incubation in PBS supplemented with 5% skimmed milk and 0.05%
Tween 20 for 1 h at room temperature, membranes were incubated in
primary antibody solution in PBS supplemented with 5% skimmed
milk and 0.05% Tween 20 for an additional 1 h at room temperature.
After washes in PBS supplemented with 0.05% Tween 20, immuno-
reactivity was revealed using a horseradish peroxidase-conjugated
secondary antibody (1:10,000) and the ECL chemiluminescent rea-
gent (Perbio).
Immunofluorescence Microscopy—HEK 293 cells transiently trans-
fected by 2 g of FLAG-MT1 together with 1 g of RGSZ1-YFP cDNA
were grown on sterile coverslips. 48 post-transfection, cells were
stimulated, or not, by 107 M melatonin for 15 min at 37 °C, washed
three times in PBS, and fixed with 4% paraformaldehyde in PBS for
15 min. After blocking with 3% BSA in PBS for 30 min, cells were
incubated with monoclonal anti-FLAG M2 (1:500) antibodies in PBS
containing 0.3% BSA for 1 h at room temperature. Coverslips were
then washed three times with PBS and incubated with Cy3-conju-
gated goat anti-mouse antibodies (1:800) in PBS containing 0.3%
BSA for 40 min at room temperature. Coverslips were mounted and
analyzed by confocal laser microscopy (Leica TCS SP2 AOBS).
Production and Purification of HA-RGSZ1—To express HA-RGSZ1
as a GST fusion protein, restriction sites for BamHI and XhoI were
introduced immediately adjacent to the initiation and termination
codons by PCR of the plasmid encoding HA-RGSZ1 using the Phu-
Purification of GPCR-associated Protein Complexes
1558 Molecular & Cellular Proteomics 7.8
 at M
cG
ill Univ Libr Serials on Novem
ber 25, 2008 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
sion High-Fidelity DNA Polymerase. After digestion by BamHI and
XhoI, the resulting insert was ligated into pGEX-4T-1 vector. DNA
sequences were confirmed by sequencing. The resulting plasmid was
transformed into BL21(DE3) cells (Invitrogen), and cells were grown in
LB medium containing 50 g/ml ampicillin. Expression of GST-HA-
RGSZ1 protein was induced by adding 1 mM isopropylthiogalactoside
(Sigma) to midlog cultures. Cultures were harvested after 7 h at 37 °C.
Cells were centrifuged at 6000  g for 15 min, and the pellet was
stored at 20 °C. For purification of HA-RGSZ1, the pellet was re-
suspended in cold PBS containing protease inhibitor mixture EDTA-
free, crushed with an Ultra-Turrax T25, and sonicated. After adding
1% Triton X-100 (Sigma), the cell suspension was centrifuged at
10,000 g for 30 min, and the supernatant was collected and applied
to glutathione-agarose beads (Sigma) that had been equilibrated with
1% Triton X-100 in PBS. After extensive washes, HA-RGSZ1 proteins
were eluted by 0.04 unit/l thrombin (Amersham Biosciences) in 200
l of PBS (2 h at 22 °C). Eluates were applied to new, freshly prepared
glutathione-agarose beads to eliminate residual contaminant GST
and bacterial proteins. The purity of HA-RGSZ1 was assessed by
SDS-PAGE after silver staining.
[35S]GTPS Binding—[35S]GTPS binding was determined in 100
l of reaction mixture containing 20 mM HEPES, 100 mM NaCl, 20
g/ml saponin, 3 M GDP, 3 mM MgCl2, protease inhibitor mixture
EDTA-free, pH 7.4. The reaction mixture also contained CHO cell
membranes stably expressing the MT1 receptor (5 fmol), 0.2 nM
[35S]GTPS, and purified RGSZ1 with or without 1 M melatonin. The
reaction was started at 37 °C by adding [35S]GTPS and stopped at
60 min by filtration. Filters were washed with 50 mM Tris/HCl, pH 7.4,
and radioactivity was measured.
Radioligand Binding—Ovine pituitary pars tuberalis was collected,
and crude membranes were prepared essentially as described previ-
ously (17). Radioligand binding was performed with pars tuberalis mem-
branes (1.5–2 mg of protein) in 1 ml of TEM buffer (75 mM Tris, 12 mM
MgCl2, 2 mM EDTA, protease inhibitor mixture EDTA-free, pH 7.4)
containing 400 pM 2-[125I]melatonin (PerkinElmer Life Sciences) for 90
min at 37 °C. After membrane solubilization with 1% digitonin (overnight
at 4 °C) and centrifugation (90 min at 18,000  g at 4 °C), RGSZ1 was
immunoprecipitated from solubilized proteins using 10 l of polyclonal
anti-RGSZ1 antibodies preadsorbed on protein G-Sepharose beads.
Beads were washed, and radioactivity was measured after rapid filtra-
tion through GF/F glass fiber filters (Whatman).
RESULTS
Optimization of the Peptide Affinity Chromatography—
Metal affinity chromatography on an Ni-NTA matrix was cho-
sen to purify proteins interacting with the amino-terminally
His6-tagged C-tails of MT1 and MT2 (61 and 59 amino acids
long, respectively) in whole brain lysates. Binding of His6-
tagged proteins is maintained under low concentrations of
imidazole, which is known to minimize nonspecific binding to
Ni-NTA-agarose beads by competing for nickel ion binding
with dispersed histidine residues in proteins. To determine the
optimal imidazole concentration, beads were incubated with
different amounts of brain lysates in the presence of different
imidazole concentrations. After several washes, retained pro-
teins were recovered and quantified (Fig. 1A). In the absence
of imidazole, the nonspecific binding was high and increased
concurrently to the amount of brain proteins added. At 20 mM,
the nonspecific binding was dramatically decreased irrespec-
tive of the amount of lysate used. Further increase in the
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FIG. 1. Optimization of the peptide affinity chromatography conditions. A, determination of the optimal concentration of imidazole to
minimize nonspecific binding on the beads. Different amounts of brain proteins were added to non-coated beads (20 l) and incubated
overnight at 4 °C in the presence or absence of 10 or 20 mM imidazole. After washes, proteins were eluted from the beads, and the nonspecific
binding was quantified. B, determination of the optimal amount of brain protein lysates. Non-coated beads (20 l) were incubated with 2, 4,
6, 8, or 10 mg of protein lysates in the presence of 20 mM imidazole overnight at 4 °C. After washes, proteins were eluted from the beads, and
the nonspecific binding was quantified. C, determination of the binding kinetics of the His6 (6xHis)-tagged peptides to the beads. 500 g of
His6-tagged peptides were dissolved in a binding buffer containing 20 mM NaH2PO4, 6 M urea, pH 8, at 1 mg/ml. Absorbance of the peptide
solutions was measured at 280 nm after 15, 30, 60, and 90 min of incubation with beads. D, determination of the amount of brain proteins
specifically recruited by the C-tails of MT1 and MT2. 10 mg of brain protein lysate were incubated with 20 l of beads coated with His6-tagged
baits in the presence of 20 mM imidazole overnight at 4 °C. After washes, the amount of retained proteins was quantified. C, non-coated beads.
Results are expressed as mean  S.E. (n  5 for non-coated beads, n  3 for MT1, and n  6 for MT2).
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amount of brain lysate (up to 10 mg of protein) did not change
the level of nonspecific binding (10–12 g) (Fig. 1B). We thus
incubated Ni-NTA beads with 10 mg of brain lysate in the
presence of 20 mM imidazole in all further experiments.
We then determined the binding kinetics of the His6-tagged
peptides to the Ni-NTA beads in phosphate buffer at pH 8, the
optimal pH for binding of His6-tagged peptides (according to
the manufacturer) and for the preservation of protein complexes
(18). Binding of peptides was rapid and reached a plateau after
30 min. After 90 min, 295 21 g (n 4) and 351 16 g (n
4) of His6 MT1 and MT2 C-tails, respectively, were immobilized
on Ni-NTA beads (Fig. 1C). Using these optimized experimental
settings, the C-tails of MT1 and MT2 typically recruited 80.7 
4.3 g (n  3) and 26.4  2.7 g (n  6) of proteins, respec-
tively. Under our conditions, nonspecific binding in the absence
of peptide was 11.9  1.4 g (n  6).
Functional Validation of Peptide Columns—We used the
differential presence of a PSD-95/Disc-large/ZO-1 (PDZ) do-
main binding motif in the C-tails of MT1 and MT2 to evaluate
the efficacy and specificity of our purification approach.
Whereas the C-tail of MT1 contains a functional class III PDZ
recognition motif, MT2 does not. PDZ domain-containing
proteins are prototypical scaffolding proteins that are in-
volved in the assembly of large molecular complexes.
Based on literature reports (19, 20) and our own results2
obtained from a yeast two-hybrid screen, we probed eluates
of the peptide columns for the presence of three PDZ do-
main-containing proteins, the multi-PDZ domain-containing
protein MUPP1, nNOS, and PSD-95. The use of specific
antibodies revealed the presence of MUPP1, nNOS, and
PSD-95 in eluates of the MT1 C-tail column but not in that of
control or MT2 C-tail columns (Fig. 2). These results confirm
the high specificity of our approach. In addition, we identified
three PDZ domain-containing proteins as new interacting pro-
teins for MT1. We furthermore probed the column eluates for the
presence of GRKs, which are known as specific GPCR-associ-
ated proteins (21). Indeed GRK2/3-specific antibodies con-
firmed the presence of these kinases in eluates of MT1 and MT2
C-tail columns (Fig. 2). We finally probed eluates of the peptide
columns for the presence of the  subunit of the heterotrimeric
Gi proteins known to be associated with the MT1 and MT2
receptors (22–24). As shown in Fig. 2, the MT1 C-tail and, to a
lesser extent, the MT2 C-tail retained Gi3 proteins.
Systematic Identification of MT1- and MT2-associated Pro-
teins—We then performed large scale experiments to recover
protein quantities that are sufficient for mass spectrometric
analysis. Because of the inherent limitations of the different
electrophoretic approaches, peptide column eluates were
separated in three different ways: 2D electrophoresis (150–
180 g of recruited proteins) and 1D electrophoresis using
either 10 or 5–9% polyacrylamide gradient gels. Fig. 3 illus-
trates a typical gel for each condition. Numerous 2D spots
and 1D bands were reproducibly observed on silver-stained
gels for MT1 and MT2 conditions. In agreement with Fig. 1A,
the apparent number of proteins recruited by the C-tail of MT1
was greater than for MT2. 1D and 2D control gels showed that
non-coated beads recruited very few nonspecific proteins.
Silver-stained 2D spots and 1D bands were systematically
excised and digested with trypsin, and the resulting peptides
were analyzed by MALDI-TOF and identified automatically
with the Mascot wizard algorithm or manually with Mascot,
ProFound, MS-Fit, and Aldente softwares in the NCBInr da-
tabase. Proteins unambiguously identified by mass spectrom-
etry for the C-tails of MT1 and MT2 and for the non-coated
beads are listed in Tables I and II and supplemental Table 1,
respectively. We identified 58 proteins that were retained by
the non-coated beads. These proteins, having affinity for Ni-
NTA-agarose beads, were considered as nonspecific binders
and systematically removed when found in the lists of MT1-
and MT2-interacting proteins. 40 proteins that bind to the
C-tail of MT1 and 22 proteins that bind to the C-tail of MT2
were identified. Among the 40 proteins identified for the MT1
C-tail, 30 were obtained from 2D electrophoresis, and 10 were
obtained from 1D electrophoresis. Among the 22 proteins
identified for the MT2 C-tail, 11 were obtained from 2D elec-
trophoresis, and 11 were obtained from 1D electrophoresis.
For each C-tail, different  and  isoforms of tubulin were2 J. Guillaume and R. Jockers, unpublished data.
WB anti -MUPP-1
WB anti -nNOS
WB anti -PSD-95
C        + MT1 + MT2     L
WB anti -GRK2/3
WB anti -Giα3
FIG. 2. Detection of PDZ domain-containing proteins, Gi3, and
GRK2/3 by immunoblotting. 20 l of beads coated with His6-tagged
MT1 and MT2 C-tails were incubated with 10 mg of protein lysates
from mouse brain. Beads were washed, and recruited proteins were
eluted with 50 l of 2% SDS in PBS. 10 l were separated by
SDS-PAGE and transferred to nitrocellulose membranes. Immuno-
blotting was performed with antibodies raised against three PDZ
domain-containing proteins, polyclonal anti-MUPP1 (1:10,000), poly-
clonal anti-nNOS (1:1000) and monoclonal anti-PSD-95 (1:2000);
against Gi3 (1:1000); and against GRK2/3 (1:1000). C, negative con-
trol, beads without peptide; L, brain lysate (20 g). WB, Western blot.
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identified from 1D electrophoresis (10 and 5–9% gradient
gels), but the corresponding spots, although easily noticeable
from 2D gels, were not excised for identification. If  and 
isoforms of tubulin are not taken into account, separation of
samples by 1D electrophoresis allowed the identification of
eight and nine additional high molecular mass proteins (in-
cluding seven proteins of molecular mass 150 kDa) for MT1
and MT2, respectively. This significant increase in the number
of identified interacting proteins (20% of the MT1 and 41% of
the MT2 interactomes) clearly illustrates that separation of
column eluates by 1D electrophoresis is complementary to 2D
electrophoresis. Identified proteins showed localization to dif-
ferent subcellular compartments (plasma membrane, cytosol,
and cytoskeleton) and could be divided into five distinct
groups: “membrane proteins,” “signaling proteins,” “cytoskel-
eton proteins,” “chaperones and stress response proteins,”
and a last group, classified as “others,” containing the remain-
ing proteins for which the function is not well described.
Validation of MT1- and MT2-associated Proteins by Immu-
noblotting Screen—Using specific antibodies, we next per-
formed an immunoblotting screen to estimate the overall re-
liability of our mass spectrometry data and to quantify the
relative amount of proteins that are recruited by both C-tails.
Seven different antibodies were tested and confirmed the
presence of the interacting protein identified by MALDI-TOF,
demonstrating the high quality of our mass spectrometric
data (Fig. 4). These experiments validated common interac-
tion partners for both receptors, such as the tubulin  and 
isoforms, the catalytic subunit of the protein phosphatase
PP2A, and the PKC 2, and showed higher recruitment with
the C-tail of MT1 compared with MT2. The immunoblotting
screen also confirmed MT1-specific interacting partners, such
as 14-3-3 ; the ubiquitin thiolesterase otubain 1 (OTUB1),
which is known to express different alternatively spliced forms
(25); and an RGSZ1 splice variant migrating at 36 kDa as
reported previously in bovine brain (26). In addition, validation
of 14-3-3 , otubain 1, and the catalytic subunit of PP2A
demonstrates the reliability of MALDI-TOF identifications from
1D gels. Using other antibodies, we also demonstrated the
presence of the regulatory subunit A/ associated with the
catalytic subunit of PP2A and another isoform of 14-3-3 (14-
3-3 ) in the MT1 C-tail eluates (supplemental Fig. 1). Both
C-tails also recruited the  isoform of tubulin.
Validation of the Interaction between the MT1 Receptor and
RGSZ1 in Living Cells—RGS proteins are signaling modula-
tors of heterotrimeric G proteins that increase their rate of
GTP hydrolysis. Recent observations indicate that RGS pro-
teins regulate G protein-dependent signaling not only in a G
protein-specific manner but also in a receptor-specific man-
ner (27–30). The molecular basis for receptor specificity is still
poorly understood. However, the recruitment of RGS proteins
into receptor-associated complexes, as suggested by our
3 11
Non-coated beads                               + MT1 + MT2
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FIG. 3. 2D and 1D electrophoresis separation of the MT1 and MT2 C-tail-associated protein complexes. Mouse brain protein complexes
recruited by the Ni-NTA-immobilized C-tail of MT1 and MT2 receptors were separated by 2D (A) or 1D electrophoresis on a 10% (B) or 5–9%
gradient polyacrylamide gel (C) and silver-stained. A typical gel for each condition is shown. C, negative control, beads without peptide. The
arrows indicate the position of RGSZ1.
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TABLE I
MALDI-TOF mass spectrometry identification of protein complexes associated with the C-tail of MT1 receptor
Trypsin-digested proteins were analyzed by MALDI-TOF, and searches were carried out automatically using Mascot wizard software or
manually using four different algorithms (Mascot, ProFound, MS-Fit, and Aldente) from the comprehensive nonredundant protein sequence
database NCBInr. ND, not determined; CLIP, cytoplasmic linker protein.
NCBI
accession no.
Protein identity
Theoretical
parameters
Observed
parameters
Matched
peaks/
selected
peaks
Sequence
coverage
Electrophoretic
separation
Identified
with MT2Molecular
mass
pI
Molecular
mass
pI
kDa kDa %
Membrane protein
47059002 Solute carrier family 4, sodium
bicarbonate cotransporter,
member 5
124 8.4 125 6.5 9/46 13 2D 
109459952 Similar to transient receptor
potential cation channel,
subfamily M, member 6
248 8.7 158 ND 16/58 10 1D (5–9%) 
17481296 Vomeronasal receptor 1 A12 35 9.3 28 7.8 5/35 25 2D 
Signal transduction
3065925 14-3-3 protein  28 4.8 31 ND 7/39 36 1D 
15928666 Adenylate kinase isoenzyme 1 22 5.7 21 4.5 6/25 34 2D 
3024067 Casein kinase II subunit  45 7.9 43 7.5 5/26 25 2D 
6753490 COP9 signalosome subunit 4 47 5.6 42 5.8 9/54 37 2D 
21312314 Dual specificity protein
phosphatase 3
20 6.6 20 6.1 10/38 61 2D 
81912670 PKC 2 47 4.7 60 7.5 5/22 26 2D 
17512397 Ppp2cb protein 32 5.5 32 ND 7/44 28 1D 
41152502 Rabphilin 3A-like (Noc2) 34 9.1 26 7.7 9/53 25 2D 
6180019 Regulator of G-protein signaling
20 (RGSZ1)
27 5.2 31 6.5 5/44 48 2D 
45219891 Ubiquitin-specific peptidase 5
(isopeptidase T)
97 4.9 125 ND 12/62 16 1D (5–9%) 
32484336 Ubiquitin thiolesterase
(Otub1 protein)
31 4.8 32 ND 5/22 28 1D 
Cytoskeleton
22122615 ARP1 actin-related protein 1
homolog B
42 6.0 45 6.8 7/47 30 2D 
13508541 CLIP-associating protein 1 44 6.6 44 8.6 13/68 56 2D 
6680924 Cofilin-1 (nonmuscle isoform) 19 8.2 18 9.1 9/45 57 2D 
6671746 Cofilin-2 (muscle isoform) 19 7.6 18 8.2 7/38 48 2D 
24657655 Cytoplasmic linker protein 2 112 6.1 88 9.0 8/53 18 2D 
9790219 Destrin 19 8.2 17 9.1 11/26 50 2D 
487851 Dynamin 85 6.0 105 7.8 13.36 20 2D 
35193307 Dynamin 1 96 6.6 105 7.6 9/43 8 2D 
14193692 Glial fibrillary acidic protein 47 5.0 43 7.5 5/25 16 2D 
25955543 Glial maturation factor,  17 5.1 17 5.3 4/25 38 2D 
2119280 Kinesin 101 5.6 158 ND 11/58 15 1D (5–9%) 
18859641 Myosin heavy polypeptide 7 222 5.6 100 ND 23/76 16 1D (5–9%) 
62825944 Tubulin, 1Ca 50 4.9 160 ND 13/73 46 1D/1D (5–9%) 
21595026 Tubulin, 3b 50 4.8 50 ND 7/34 24 1D/1D (5–9%) 
Chaperone and
stress response
6671702 Chaperonin subunit 5 () 60 6.0 65 6.2 9/42 38 2D 
126521835 Chaperonin subunit 2 () 58 6.0 56 6.7 17/78 43 2D 
110625998 DnaJ homolog, subfamily B,
member 11
41 5.9 40 7.1 9/36 37 2D 
Others
40068507 Collapsin response mediator
protein (CRMP) 1
62 6.6 64 7.4 8/44 21 2D 
24418919 Brain glycogen phosphorylase 96 6.3 105 ND 22/82 33 1D (5–9%) 
40254595 Dihydropyrimidinase-like 2 63 6.0 66 6.9 21/47 61 2D 
21362303 Hypothetical protein LOC-67826 47 5.5 47 6.1 14/50 48 2D 
21313286 Hypothetical protein LOC-76824 32 5.8 40 6.3 5/26 22 2D 
12857982 Unnamed protein product 18 6.1 18 6.1 7/27 62 2D 
12860873 Unnamed protein product 29 5.4 25 5.2 4/28 14 2D 
26344447 Unnamed protein product 40 6.2 48 5.8 9/52 30 2D 
7422551 Unnamed protein product 72 5.0 72 5.4 15/77 32 2D 
a Other isoforms of tubulin  chain were identified (NCBI accession numbers 32015, 202225, 6678469, 6755901, 27762594, 34740335,
54035478, and 80474380).
b Other isoforms of tubulin  were identified (NCBI accession numbers 29145006 and 31981939).
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data, represents one possible explanation. To confirm the
physiological association of RGSZ1 with the full-length MT1
receptor, we co-expressed either FLAG-MT1 or FLAG-MT2
constructs together with HA-tagged RGSZ1 in HEK 293 cells.
Co-immunoprecipitation experiments performed with anti-
FLAG antibodies revealed that only MT1 co-immunoprecipi-
tated RGSZ1 in both resting and melatonin-activated cells
(Fig. 5A). The specificity of the interaction was further vali-
dated using RGS10 as a negative control. As shown in Fig.
5B, immunoprecipitation of FLAG-MT1 or FLAG-MT2 did not
co-immunoprecipitate RGS10. As an additional control, we
further performed immunofluorescence experiments in HEK
293 cells co-expressing FLAG-MT1 together with RGSZ1-YFP
(Fig. 5C). Consistent with our biochemical experiments, a
distinct co-localization at the plasma membrane was ob-
served in these cells irrespective of the activation state of the
receptor.
To evaluate the functional relevance of RGSZ1 coupling
to the MT1 receptor, we determined the effect of increasing
concentrations of purified RGSZ1 on [35S]GTPS binding in
response to 1 M melatonin using CHO cell membranes
stably expressing high levels of MT1 (Fig. 5D). As expected,
the agonist melatonin stimulated [35S]GTPS binding (to
221  27%), indicating efficient MT1 protein coupling in the
absence of RGSZ1. When purified RGSZ1 was added, an
increase in the [35S]GTPS binding was observed in re-
sponse to the agonist as reported previously for RGS4 (31).
This assay is designed to promote [35S]GTPS binding in
the presence of RGS proteins as GTP hydrolysis becomes
rate-limiting due to saturation of GDP-GTP exchange at
high concentrations of receptor (31). This results in local
depletion of inactive heterotrimeric G-GDP that is reversed
by RGS GTPase-activating protein activity. Indeed purified
RGSZ1 accelerated melatonin-promoted [35S]GTPS bind-
TABLE II
MALDI-TOF mass spectrometry identification of protein complexes associated with the C-tail of MT2 receptor
Trypsin-digested proteins were analyzed by MALDI-TOF, and searches were carried out automatically using Mascot wizard software or
manually using four different algorithms (Mascot, ProFound, MS-Fit, and Aldente) from the comprehensive nonredundant protein sequence
database NCBInr. ND, not determined.
NCBI
accession no. Protein identity
Protein
parameters
Observed
parameters
Matched
peaks/
selected
peaks
Sequence
coverage
Electrophoretic
separation
Identified
with MT1Molecular
mass pI
Molecular
mass pI
kDa kDa %
Membrane protein
6978547 Na/K-ATPase 3 subunit 113 5.3 105 ND 12/59 16 1D (5–9%) 
26251984 Na/K-ATPase 3 (fragment) 33 5.2 33 8.5 4/27 30 2D 
62660468 Similar to WD repeat
membrane protein
150 5.9 125 ND 12/66 10 1D (5–9%) 
Signal transduction
1262300 Casein kinase II  subunit 45 7.9 38 9.5 5/46 23 2D 
400704 Catenin -1 (p120-catenin) 102 6.5 110 ND 10/55 16 1D (5–9%) 
56205529 Clathrin heavy polypeptide 194 5.5 180 ND 16/39 13 1D (5–9%) 
21312314 Dual specificity phosphatase 3 21 6.1 21 6.1 7/58 50 2D 
33438248 MKIAA0034 protein (clathrin
heavy chain)
192 5.4 190 ND 22/67 17 1D (5–9%) 
31158356 PKC 2 47 4.7 41 9.0 6/44 28 2D 
45477181 Tyrosine-protein phosphatase,
nonreceptor type 13
272 5.9 250 ND 7/20 5 1D (5–9%) 
Cytoskeleton
11993948 Glial maturation factor  17 5.3 18 4.6 5/24 38 2D 
547890 Microtubule-associated
protein 2
203 4.8 250 ND 8/34 7 1D (5–9%) 
6678469 Tubulin, 1Ca 50 4.9 55 ND 9/49 30 1D/1D (5–9%) 
12963615 Tubulin 3b 50 4.8 60 ND 13/46 44 1D/1D (5–9%) 
Chaperone and
stress response
6754256 Heat shock protein 9 74 5.9 75 5.9 12/61 23 2D 
97536358 Heat shock protein, 105 kDa
(HSP-E7I)
96 5.4 65 4.5 6/41 13 2D 
Others
24418919 Brain glycogen phosphorylase 97 6.3 100 ND 14/51 21 1D (5–9%) 
7710012 Crystallin,  34 5.4 35 5.3 4/40 23 2D 
40254595 Dihydropyrimidinase-like 2 63 6.0 70 7.0 13/64 31 2D 
66912155 mUp76 (Calpain 3) 77 5.6 60 7.7 8/38 25 2D 
1334146 Unnamed protein product 30 5.3 29 4.2 5/36 32 2D 
26326811 Unnamed protein product 120 8.8 158 ND 10/66 16 1D (5–9%) 
a Other isoform of tubulin  chain was identified (NCBI accession number 32015).
b Other isoforms of tubulin  chain were identified (NCBI accession numbers 13542680 and 62663465).
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ing, reaching maximal values at 108 M RGSZ1 (305  8%,
p  0.02).
To confirm that the presence of RGSZ1 in MT1-associated
protein complexes is physiologically relevant, we performed
immunoprecipitation studies with ovine pituitary pars tuberalis
tissue samples known to express significant amounts of en-
dogenous MT1 receptors (32, 33) and RGSZ1 (data not
shown). In the absence of high affinity anti-MT1 antibodies,
receptors were labeled with the specific 2-[125I]iodomelatonin
radioligand, and protein complexes were solubilized and im-
munoprecipitated with anti-RGSZ1 antibodies. As shown in
Fig. 5E, significant amounts of radiolabeled MT1 were precip-
itated in the presence of anti-RGSZ1 antibodies, demonstrat-
ing the existence of MT1-RGSZ1 complexes in native tissue.
DISCUSSION
In this study, we present an improved proteomics approach
coupling peptide affinity chromatography with 1D and 2D elec-
trophoresis separation and mass spectrometry for the identifi-
cation of proteins interacting with the C-tail of GPCRs. To date,
this is the first study proposing the use of an adapted and
optimized IMAC for the identification of protein complexes.
Using this approach, we identified 40 proteins that bind to the
C-tail of MT1 and 22 proteins that bind to the C-tail of MT2.
Interactions between GPCRs and associated proteins are
known to involve the intracellular loops, the transmembrane,
and the C-tail of GPCRs. The most abundant and the best
studied are proteins interacting with the C-tail of GPCRs. This
C-tail, recently nicknamed the “magic” tail by Bockaert et al.
(7), serves as a scaffold for the formation of a signalosome
containing diverse effectors and clustering proteins. The na-
ture of the interaction proteins that bind to the C-tail of GPCRs
can determine not only its targeting to a specific cellular
compartment but also its association with other signaling or
structural proteins and the fine tuning of its signal transduc-
tion such as desensitization and resensitization (34). There-
fore, the identification of the protein complexes associated
with GPCRs constitutes an important step toward the devel-
opment of new drugs. Indeed these compounds could be
used to disrupt or strengthen specific interactions between
GPCRs and their associated proteins. Different proteomics
approaches coupling peptide affinity chromatography and
mass spectrometry have been developed to identify proteins
interacting with the C-tail of GPCRs and have proven their
efficacy in identifying protein complexes associated with the
C-tail of GPCRs (7, 35). However, these approaches, which
used either short peptides encompassing a specific interac-
tion motif such as the PDZ ligand of the 5-HT2A and 5-HT2C
receptors (12, 13) or the entire C-tail expressed as a GST
fusion protein such as for the 5-HT2C receptor (11), have
shown limitations. They were either too restrictive to some
particular interaction proteins (PDZ domain-containing pro-
teins) or used GST fusion proteins as “bait” leading to in-
creased background.
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FIG. 4. Validation of MALDI-TOF-
identified binding proteins by immu-
noblotting. Immobilized His6-tagged
MT1 and MT2 C-tails were incubated
with 10 mg of protein lysates from
mouse brain. Recruited proteins were
eluted with 50 l of 2% SDS in PBS. 10
l were separated by SDS-PAGE and
transferred to nitrocellulose mem-
branes. Immunoblotting was performed
with monoclonal anti-tubulin  (1:2000),
monoclonal anti-tubulin  (1:2000),
monoclonal anti-PP2A catalytic subunit
(1:1000), polyclonal anti-PKC  (1:1000),
monoclonal anti-14-3-3  (1:1000), poly-
clonal anti-otubain 1 (1:2000), and poly-
clonal anti-murine RGSZ1 (1:500) anti-
bodies. C, negative control, non-coated
beads; L, brain lysate (20 g). WB, West-
ern blot.
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IMAC has several advantages. Indeed the Ni-NTA interac-
tion with the His6 tag is highly specific and strong enough to
resist detergents, induces low nonspecific binding due to the
addition of low concentrations of imidazole (Fig. 1A), and uses
pH conditions optimal for the preservation of protein com-
plexes and to minimize nonspecific interactions (18). More-
over the His6 tag is much smaller (955 Da) than other com-
monly used tags, such as the GST tag (26 kDa), contributing
to the reduction of nonspecific interactions between mice
brain proteins and the tag. The use of chemically synthesized
bait of high purity also considerably reduced nonspecific
binding in contrast to GST-tagged bait produced in bacteria
for which the 2D protein pattern is often complex due to the
presence of bacterial proteins, which bind to the GST tag
and/or fusion peptide during bait production in bacteria, and
the major brain proteins. After optimizing parameters such as
the concentration of imidazole, the amount of brain protein
lysates, and the incubation time for bait coupling on the
beads, we were able to considerably reduce nonspecific bind-
ing to 0.1% (10 g from 10 mg of total brain proteins). Using
these experimental settings, 80 and 25 g of brain proteins
(from 10 mg) were specifically recruited by the C-tails of MT1
and MT2, respectively.
Most studies aiming to identify protein complexes associ-
ated to the C-tail of GPCRs have used 2D electrophoresis for
protein separation. This technique minimizes the number of
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FIG. 5. Functional interaction between RGSZ1 and MT1 in cells. HEK 293 cells transiently expressing either FLAG-MT1 or FLAG-MT2 were
co-transfected with HA-RGSZ1 (A) or Myc-RGS10 (B). 48 h post-transfection, cells were stimulated, or not, by melatonin (107 M for 15 min)
and lysed. The MT1 and MT2 receptors were immunoprecipitated by anti-FLAG antibodies, and precipitates were analyzed by Western blot for
the presence of co-immunoprecipitated HA-RGSZ1 (A) or Myc-RGS10 (B) using anti-tag antibodies. C, confocal images of HEK 293 cells
co-expressing FLAG-MT1 with RGSZ1-YFP. Receptors were immunostained with anti-FLAG antibodies, and RGSZ1 was revealed by its YFP
fluorescence. The co-localization of both proteins was evaluated with the ImageJ co-localization highlighter plug-in. D, [35S]GTPS binding to
MT1-expressing CHO cells without (black bars) or with 1 M melatonin (white bars) in the absence or presence of the indicated concentrations
of purified RGSZ1. Data represent the mean  S.E. of three experiments, each conducted in triplicate. Statistical significance was determined
using the Mann-Whitney test. *, p  0.05. E, co-immunoprecipitation of 125I-melatonin (125I-MLT)-labeled MT1 receptors with anti-RGSZ1
antibodies. Nonspecific binding was estimated by performing immunoprecipitation using a pool of five non-relevant polyclonal antibodies. Data
represent the mean  S.E. of two experiments. IP, immunoprecipitate; WB, Western blot; NS, nonspecific binding.
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potential candidates as it is not adapted for selection of
hydrophobic, basic, and large proteins. To enlarge the num-
ber of interacting proteins and obtain a more detailed inter-
actome, we performed 2D electrophoresis and 1D electro-
phoresis using 10 and 5–9% gradient gels. The utilization of
1D electrophoresis was possible because of the small size of
the His6-tagged baits (7.16 kDa for the MT1 and 6.80 kDa for
the MT2 C-tails) in contrast to the larger GST baits whose size
makes the use of 1D electrophoresis difficult notably for the
identification of proteins with molecular weights similar to that
of the bait. Among the 40 proteins identified for the MT1 C-tail,
30 were obtained from 2D electrophoresis, and 10 were ob-
tained from 1D electrophoresis. Among the 22 proteins iden-
tified for the MT2 C-tail, 11 were obtained from 2D electro-
phoresis, and 11 were obtained from 1D electrophoresis.
These results demonstrated that the combination of 1D and
2D electrophoresis greatly increased the number of proteins
identified and that the use of only 2D electrophoresis led to an
underestimation of multiprotein complexes associated to the
C-tail of GPCRs. Identification of proteins by MALDI-TOF
mass spectrometry, which only provides peptide mass finger-
prints but no sequence information, is known to require prior
high quality purification. However, our study has shown that
several proteins separated by 1D electrophoresis could be
unambiguously identified by MALDI-TOF because of the sen-
sitivity of the apparatus and the stringency of our experimen-
tal conditions that considerably reduce the nonspecific bind-
ing and consequently the complexity of the protein
electrophoretic pattern for MS identification.
Several previously described GPCR-associated proteins
were identified. In this study, we showed that the C-tail of MT1
recruited 14-3-3  and destrin, proteins shown to be associ-
ated with mGluR5 (36), and dynamin 1, a protein known to
interact with 5-HT2C (11) and mGluR5 (36). Some proteins
found in MT2 C-tail eluates were also already described as
GPCR-binding proteins, such as the clathrin heavy chain and
Na/K-ATPase 3 subunit for mGluR5 (36) and microtubule-
associated protein 2 (MAP2) for mGluR5 (36) and 5-HT4a (13).
Ten common members of MT1 and MT2 C-tail-associated
complexes were identified, including well known GPCR-asso-
ciated proteins such as Gi proteins and GRK2/3 and other
proteins such as dual specificity phosphatase 3 (DSP3), a
protein able to dephosphorylate protein substrates containing
both phosphotyrosine and phosphoserine or phosphothreo-
nine residues, with specificity for the mitogen-activated pro-
tein kinases (MAPKs) Erk2 and c-Jun NH2-terminal kinase
(JNK) (37). The serine/threonine protein kinase casein kinase II
(CK2), recently shown to be involved in phosphorylation of the
M3 muscarinic receptor (38), was also found as a common
interaction member of MT1 and MT2 C-tails. Interestingly a
role for CK2 consensus sites within GPCR C-tails has been
proposed in targeting GPCRs to the -arrestin-dependent
pathway (39). PKC 2 and tubulins  and  were also recruited
by both MT1 and MT2 C-tails and confirmed by immunoblot-
ting. PKC 2 is specifically expressed in the mouse brain (40)
and is a member of the atypical PKC subfamily. Tubulins 
and  constitute the basic building block of microtubules, the
major components of the cytoskeleton involved in many es-
sential processes (41). Tubulins  and  have been shown to
interact with the C-tails of mGluR7a and mGluR1a, respec-
tively (42–44), and we recently demonstrated a modulation of
melatonin receptors and G protein function by microtubules
(45).
Among the proteins involved in signal transduction that
were specifically recruited by the C-tail of MT1, we identified
two proteins involved in the deubiquitination pathway and
members of the ubiquitin-specific processing proteases,
otubain 1 (confirmed by Western blot) and ubiquitin-specific
peptidase 5, also known as isopeptidase T. Subunit 4 of
COP9, a multiprotein complex of the ubiquitin-proteasome
pathway, was also identified. The  isoform of the catalytic
subunit of protein phosphatase 2A (PPP2cb) was also found.
PP2A is a highly conserved serine/threonine phosphatase that
plays pivotal roles in diverse cellular functions (46). A direct
interaction between this subunit and the C-tail of the iono-
tropic N-methyl-D-aspartate receptor has already been dem-
onstrated by yeast two-hybrid and immunoprecipitation
experiments (47). In addition, PP2A has been shown to co-
immunoprecipitate with mGluR5 and regulates mGluR5-de-
pendent mitogen-activated protein kinase/extracellular sig-
nal-regulated kinase kinase (MEK)/ERK phosphorylation in
neurons (48). Finally three PDZ domain-containing proteins
were also identified as specific MT1-associated proteins by
immunoblot: MUPP1, nNOS, and PSD-95. We failed to iden-
tify these three proteins by MS probably due to their low
abundance within the gels. MUPP1 has been characterized
previously as a direct interaction partner of MT1 that promotes
Gi protein coupling of this receptor (49). Neuronal NO syn-
thase has been previously proposed as a potential interacting
candidate of the MT1 receptor (20). However, nothing is
known about the functional consequences of this particular
interaction. PSD-95 is a prototypical scaffolding protein highly
enriched in the PSD that belongs to the membrane-associ-
ated guanylate kinase family (51). PSD-95 interacts with a
host of proteins of diverse functions, most notably N-methyl-
D-aspartate receptors, and regulates the functional integration
of these receptors into signaling complexes in PSD (51). In-
teraction between PSD-95 and GPCRs has already been de-
scribed as with the somatostatin receptors SSTR4 and SSTR1
(52) and dopamine D1 receptors (53). The coupling of PSD-95
with the C-tail of D1 receptors has been shown to regulate the
surface expression and the intracellular trafficking of the re-
ceptors and to inhibit D1 receptor-mediated signaling in
mammalian cells (53). Gi3 proteins were also detected by
immunoblot but again failed to be identified by MS. In con-
trast, Gi was easily detectable by MS using the tandem
affinity purification (TAP) approach (24) suggesting that the
C-tail of MT1 and MT2 is involved in Gi binding but that
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further molecular determinants provided by the entire recep-
tor are needed for efficient Gi recruitment.
By our approach, we were also able to identify membrane
proteins, which are often undetectable when using 2D elec-
trophoresis. The majority of these membrane proteins were
identified following 1D electrophoresis. Surprisingly, however,
some of them were identified by 2D electrophoresis, such as
the vomeronasal type-1 receptor A12. Vomeronasal receptors
are GPCRs that bind pheromones and are responsible for
various behavioral and neuroendocrine responses between
individuals (54). Heterodimerization between this vomeronasal
receptor and the melatonin MT1 receptor remains to be dem-
onstrated. The number of identified proteins interacting with
the MT2 C-tail was lesser than that of MT1. However, several
interesting proteins were identified, including catenin -1, also
known as p120-catenin. This protein is a regulator of cadherin
stability and an important modulator of Rho GTPase activities
(55). -Catenin was first identified through its interaction with
presenilin-1, the molecule most frequently mutated in familial
Alzheimer disease (56), and shown to interact with mGluR1
receptors by co-immunoprecipitation experiments using rat
brain homogenates and dissociate from mGluR1 upon acti-
vation by L-glutamate (57).
Approaches based on isolated GPCR subdomains, such as
the C-tail, have to be compared with the recently described
TAP approach that uses the entire receptor as bait to pull
down GPCR-associated protein complexes (24). A careful
analysis of the advantages and drawbacks shows that both
approaches are rather complementary than mutually exclu-
sive. Whereas the entire receptor allows the purification of
protein complexes formed in intact cells, the C-tail approach
is more easily accessible for comparing the interactomes of
different tissues and under different experimental conditions
(different pathophysiological models and pharmacological
treatments). A complete list of advantages and drawbacks of
both approaches is presented in supplemental Table 2. In
contrast to the TAP approach, which is, by itself, a co-immu-
noprecipitation performed from living cells, interactions be-
tween the bait and the proteins identified by approaches
using GPCR subdomains need to be confirmed in intact
cells with the full-length receptor ideally expressed endog-
enously. In this study, we validated the interaction between
the MT1 receptor and RGSZ1, a brain-specific protein that
belongs to the RGS family (26, 58, 59). RGS proteins have
been described as signaling modulators of heterotrimeric
G proteins that increase their rate of GTP hydrolysis and
terminate signaling (60–62) and more recently as proteins
able to directly interact with GPCRs (27, 63–65). We suc-
ceeded in confirming the interaction between the MT1 re-
ceptors and RGSZ1 in cells from the ovine pars tuberalis,
which expresses both proteins endogenously, and in trans-
fected HEK 293 cells. The interaction was functional, con-
stitutive, occurred at the plasma membrane, and was only
detected with MT1 but not with MT2. The constitutive nature
of the interaction suggests precoupling of RGSZ1 to MT1 at
the basal state and molecular rearrangement within this
pre-existing complex upon agonist stimulation. This model
is in good agreement with results described for other RGS
proteins (27, 50, 63).
In conclusion, we present here a generic strategy that rep-
resents a major methodological advance for the identification
of components of GPCR C-tail-associated complexes and
overcomes the limitations of currently used genetics and pro-
teomics approaches. Moreover this approach appears to be
complementary to recently developed proteomics ap-
proaches based on the use of the entire GPCR as bait. Fea-
tures of this new strategy are the use of chemically synthe-
sized His6-tagged baits and IMAC that resulted in low
nonspecific binding, pH conditions that preserved the integ-
rity of associated protein complexes, and the association of
1D and 2D gel electrophoresis for protein separation that
increases the number of identified interaction partners. These
62 candidates will now provide a basis for future cellular
studies. Our approach represents a new opportunity for the
study of protein complexes associated with GPCRs that can
be used to compare GPCR interactomes from different tis-
sues and can be extended to the identification of GPCR-
associated complexes under pathological conditions or after
in vivo pharmacological treatments. Several interactions
strongly depend on reversible post-translational modifications
such as phosphorylation. In vitro phosphorylation of the ser-
ine, threonine, and tyrosine residues of GPCR subdomains or
the replacement of these residues by phosphomimetic amino
acids are two further extensions of our approach to specifi-
cally retain those complexes whose interaction depends on
receptor phosphorylation.
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